{
    "2019-11-13": [
        [
            {
                "time": "2018-03-15",
                "original_text": "UPDATE 1-J&J blockbuster loses ground to biosimilars despite Quebec court ruling",
                "features": {
                    "keywords": [
                        "J&J",
                        "blockbuster",
                        "loses ground",
                        "biosimilars",
                        "Quebec court ruling"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?",
                "features": {
                    "keywords": [
                        "Investors",
                        "Johnson & Johnson",
                        "Stock",
                        "Shopping Lists"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "UPDATE 1-N.Y. insurance regulator notifies opioid makers, distributors of enforcement action -sources",
                "features": {
                    "keywords": [
                        "N.Y.",
                        "insurance regulator",
                        "opioid makers",
                        "distributors",
                        "enforcement action"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Halozyme (HALO) Earnings & Revenues Miss Estimates in Q3",
                "features": {
                    "keywords": [
                        "Halozyme",
                        "Earnings",
                        "Revenues",
                        "Miss Estimates",
                        "Q3"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "J&J's Remicade losing ground in Quebec health plan despite court victory",
                "features": {
                    "keywords": [
                        "J&J",
                        "Remicade",
                        "losing ground",
                        "Quebec health plan",
                        "court victory"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}